A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer (Q36895058)
Jump to navigation
Jump to search
scientific article published on 29 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer |
scientific article published on 29 July 2011 |
Statements
1 reference
A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer (English)
1 reference
Brian M Wolpin
1 reference
Eunice L Kwak
1 reference
Jeffrey W Clark
1 reference
David P Ryan
1 reference
Lawrence S Blaszkowsky
1 reference
Kimmie Ng
1 reference
Jason E Faris
1 reference
Jamie Arnott
1 reference
Hui Zheng
1 reference
Thomas A Abrams
1 reference
Peter C Enzinger
1 reference
Aram F Hezel
1 reference
29 July 2011
1 reference
1 reference
1614-1620
1 reference
Identifiers
1 reference
1 reference
1 reference